Last reviewed · How we verify

NCT06694220

Impact of Tailored Preventive Exercise Program for Reducing Risk of Hip Adductors Injury

Not yet recruiting NA Last updated 19 November 2024
What this trial tests

NA trial testing Tailored preventive exercises in Adductor Strain in 40 participants. Not yet recruiting.

Timeline
20 November 2024
Primary endpoint
10 February 2025
20 February 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment40
Start date20 November 2024
Primary completion10 February 2025
Estimated completion20 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 35, male only, with Adductor Strain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted : * To investigate the impact of tailored preventive exercise program in reducing hip adductor loss of isometric strength in professional football players. * To investigate the impact of tailored preventive exercise program in reducing hip adductors to abductors strength asymmetry ratio in professional football players. * To investigate the impact of tailored preventive exercise program in reducing pain intensity during seasonal matches in professional football players. * To investigate the impact of tailored preventive exercise program on groin health and performance enhancement in professional football players.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adductor Strain

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06694220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing